Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes, Cytotoxic | 8 | 2024 | 1821 | 2.170 |
Why?
|
Multiple Myeloma | 12 | 2024 | 5181 | 1.630 |
Why?
|
B-Cell Maturation Antigen | 3 | 2024 | 140 | 1.490 |
Why?
|
Cancer Vaccines | 5 | 2019 | 1023 | 0.880 |
Why?
|
HLA-A2 Antigen | 6 | 2012 | 213 | 0.830 |
Why?
|
Cytotoxicity, Immunologic | 5 | 2020 | 1369 | 0.790 |
Why?
|
Syndecan-1 | 2 | 2012 | 165 | 0.780 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2018 | 880 | 0.770 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2019 | 4479 | 0.710 |
Why?
|
Antigens, CD | 5 | 2021 | 4026 | 0.700 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 2 | 2021 | 177 | 0.690 |
Why?
|
Antigens, Neoplasm | 4 | 2018 | 1988 | 0.670 |
Why?
|
Galectins | 1 | 2021 | 268 | 0.650 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2013 | 434 | 0.600 |
Why?
|
Blood Proteins | 1 | 2021 | 1124 | 0.550 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1836 | 0.480 |
Why?
|
Oligopeptides | 2 | 2012 | 1189 | 0.450 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2004 | 294 | 0.430 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 789 | 0.430 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1736 | 0.430 |
Why?
|
Leukemia, Myeloid | 2 | 2004 | 707 | 0.380 |
Why?
|
Lymphocyte Activation | 7 | 2021 | 5524 | 0.360 |
Why?
|
Peptides | 3 | 2018 | 4409 | 0.340 |
Why?
|
Killer Cells, Natural | 3 | 2020 | 2133 | 0.340 |
Why?
|
Plasma Cells | 1 | 2011 | 591 | 0.310 |
Why?
|
Nanoparticles | 1 | 2019 | 1905 | 0.310 |
Why?
|
Immunotherapy, Adoptive | 2 | 2019 | 1270 | 0.310 |
Why?
|
Cell Line, Tumor | 10 | 2020 | 16689 | 0.290 |
Why?
|
Receptors, Immunologic | 1 | 2012 | 1423 | 0.270 |
Why?
|
Immunotherapy | 3 | 2018 | 4445 | 0.200 |
Why?
|
Vaccines, Subunit | 2 | 2012 | 168 | 0.200 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13695 | 0.190 |
Why?
|
Dendritic Cells | 2 | 2013 | 2725 | 0.190 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2020 | 67 | 0.180 |
Why?
|
Cell Proliferation | 6 | 2021 | 10481 | 0.170 |
Why?
|
T-Lymphocytes | 2 | 2013 | 10180 | 0.150 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6314 | 0.150 |
Why?
|
K562 Cells | 2 | 2011 | 634 | 0.140 |
Why?
|
Interferon-gamma | 3 | 2013 | 3206 | 0.130 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9648 | 0.130 |
Why?
|
Apoptosis | 3 | 2021 | 9727 | 0.120 |
Why?
|
T-Lymphocyte Subsets | 2 | 2020 | 1838 | 0.110 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2013 | 57 | 0.110 |
Why?
|
Histone Deacetylases | 1 | 2018 | 728 | 0.110 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2013 | 91 | 0.110 |
Why?
|
Peptide Fragments | 3 | 2012 | 5097 | 0.110 |
Why?
|
Transcription Factors | 1 | 2012 | 12208 | 0.110 |
Why?
|
Benzoquinones | 1 | 2013 | 201 | 0.100 |
Why?
|
B-Lymphocytes | 1 | 2005 | 4665 | 0.100 |
Why?
|
Cell Degranulation | 1 | 2012 | 287 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2018 | 1348 | 0.100 |
Why?
|
Lactams, Macrocyclic | 1 | 2013 | 320 | 0.100 |
Why?
|
Cell Growth Processes | 1 | 2011 | 399 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1580 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1861 | 0.090 |
Why?
|
Transplantation, Autologous | 1 | 2014 | 2124 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2916 | 0.090 |
Why?
|
Humans | 18 | 2024 | 744343 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2013 | 805 | 0.080 |
Why?
|
Neoplasms | 1 | 2018 | 21683 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2219 | 0.080 |
Why?
|
Combined Modality Therapy | 3 | 2018 | 8642 | 0.080 |
Why?
|
Tetanus Toxoid | 1 | 2007 | 193 | 0.070 |
Why?
|
Vaccination | 1 | 2019 | 3278 | 0.070 |
Why?
|
Signal Transduction | 2 | 2020 | 23403 | 0.070 |
Why?
|
Stem Cell Transplantation | 1 | 2014 | 1620 | 0.070 |
Why?
|
Down-Regulation | 1 | 2013 | 3002 | 0.060 |
Why?
|
Receptors, Complement 3d | 1 | 2005 | 118 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1676 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2021 | 21746 | 0.060 |
Why?
|
Antigens, CD20 | 1 | 2005 | 199 | 0.060 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2004 | 329 | 0.060 |
Why?
|
Acute Disease | 2 | 2004 | 7149 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6622 | 0.050 |
Why?
|
Antigens, Surface | 1 | 2007 | 1663 | 0.050 |
Why?
|
Phenotype | 2 | 2013 | 16365 | 0.050 |
Why?
|
Antigens, CD19 | 1 | 2005 | 380 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2014 | 3586 | 0.050 |
Why?
|
Amino Acid Sequence | 2 | 2005 | 13815 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 12072 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2007 | 1284 | 0.050 |
Why?
|
Antigens | 1 | 2007 | 1466 | 0.050 |
Why?
|
Prognosis | 1 | 2021 | 29063 | 0.050 |
Why?
|
Thalidomide | 1 | 2005 | 890 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39050 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11524 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7322 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 13033 | 0.040 |
Why?
|
Immunomodulation | 1 | 2020 | 541 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2005 | 4386 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 63114 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2005 | 2988 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9438 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8436 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9274 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2005 | 307 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19229 | 0.010 |
Why?
|
CD40 Ligand | 1 | 2005 | 526 | 0.010 |
Why?
|
Immunization, Passive | 1 | 2005 | 623 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2005 | 2559 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2005 | 1607 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40561 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2005 | 3200 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57776 | 0.010 |
Why?
|
Animals | 1 | 2004 | 168757 | 0.010 |
Why?
|
Aged | 1 | 2018 | 163280 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 213383 | 0.000 |
Why?
|
Adult | 1 | 2018 | 214055 | 0.000 |
Why?
|
Male | 1 | 2018 | 350118 | 0.000 |
Why?
|
Female | 1 | 2018 | 380194 | 0.000 |
Why?
|
Concepts
(112)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_